|Bid||490.12 x 800|
|Ask||494.05 x 3100|
|Day's Range||490.06 - 501.82|
|52 Week Range||328.13 - 664.64|
|Beta (5Y Monthly)||0.32|
|PE Ratio (TTM)||18.05|
|Earnings Date||Feb 04, 2021 - Feb 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||673.13|
Best ETF picks to invest in now to get exposure to working remotely, fast connectivity, cybersecurity, genomics, robotics, vaccines, climate change, green energy, artificial intelligence and autonomous driving.
With the latest purchase of 6,50,000 additional doses, the U.S. government acquires a total of 9,50,000 doses of bamlanivimab from Eli Lilly (LLY).
Scott+Scott Continues Investigation of Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty – REGN